This report describes a female patient with myasthenia gravis who developed respiratory failure due to vocal cord paresis. The diagnosis was delayed due to the absence of other myasthenic symptoms (e.g. ptosis, muscle weakness and dysphagia). On direct laryngoscopy, her vocal cords were seen to be in the paramedian position and to move apart after the intravenous injection of edrophonium. The patient initially presented with ocular myasthenia and later returned with isolated respiratory failure. A review of the pertinent literature revealed few reports on myasthenia gravis presenting in this manner.

Keywords:
Myasthenia gravis, Respiratory failure, Vocal cord paresis
1.
Gracey DR, Howard FM, Divertie MB.: Plasmapheresis in the treatment of ventilator-dependent myasthenia gravis patient. Chest 1984;85:739–743.
2.
Fairley JW, Hughes M: Acute stridor due to bilateral vocal fold paralysis as a presenting sign of myasthenia gravis. J Laryngol Otol 1992;106:737–738
3.
Dushay KM, Zibrac JD, Jensen WA: Myasthenia gravis presenting as isolated respiratory failure. Chest 1990;97:232–233.
4.
Job A, Raman R, Gnanamuthu C: Laryngeal stridor in myasthenia gravis. J Laryngol Otol 1992;106:633–634.
5.
Foulkes CJ: Myasthenia gravis presenting as laryngeal stridor after exposure to chlorine gas. South Med J 1981;74:1423–1424.
6.
Neiman RF, Mountjoy JR, Allen EL: Myasthenia gravis focal to the larynx. Arch Otolaryngol 1975;101:569–570.
7.
Colp C, Kriplani L, Nussbaum N: Vocal cord paralysis in myasthenia gravis following anesthesia. Chest 1980;77:218–220.
8.
Schmidt-Nowara WW, Marder EJ, Feil PA: Respiratory failure in myasthenia gravis due to vocal cord paresis. Arch Neurol 1984;41:567–568.
9.
DeTroyer A, Borestein S: Acute changes in respiratory mechanics after pyridostigmine injection in patients with myasthenia gravis. Am Rev Respir Dis 1980;121:629–638.
10.
Ringqvist I, Ringqvist T: Changes in respiratory mechanics in myasthenia gravis with therapy. Acta Med Scand 1971;191:509–518.
11.
Magyer P, Szathmary I, Szobor A: Myasthenia gravis: Lung function studies without and with edrophonium chloride. Eur Neurol 1979;18:59–65.
12.
Daroff RB: The office Tensilon test for ocular myasthenia gravis. Arch Neurol 1986;43:843–844.
13.
Putman MT, Wise RA: Myasthenia gravis and upper airway obstruction. Chest 1996;109:400–404.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.